top of page

Anuria or Oliguria

Updated: May 2

The provided text outlines a comprehensive approach to evaluating and managing patients presenting with anuria or oliguria, conditions characterized by a severely diminished urine output. This approach is essential for identifying the underlying causes, which can range from pre-renal factors like shock or dehydration to renal and post-renal causes such as obstructions or kidney damage. Here's a simplified explanation based on the provided guidelines:


  • Initial Observation: The necessity to observe urine output is crucial for patients at risk of kidney issues, such as those in shock, post-operative states, or with a history of chronic kidney disease (CKD). Monitoring urine output helps in early detection of acute kidney injury (AKI), defined by specific criteria such as a significant increase in serum creatinine or a decrease in urine output to less than 0.5 ml/kg/hr over 6 hours.

  • Determining the Cause of Reduced Urine Output:

  • Re-check if the low urine output is accurately recorded, considering possible reasons like unrecorded output or patient conditions preventing normal urine collection.

  • Evaluate if the patient has advanced CKD, which could naturally result in reduced urine output.

  • Identifying the Underlying Issue:

  • Divide potential causes into pre-renal (issues before the kidney, like blood flow reduction), renal (direct kidney damage), and post-renal (obstructions in the urinary tract) for targeted investigation and treatment.

  • Initial focus should be on excluding post-renal causes since they can often be identified and remedied more straightforwardly.

  • Diagnostic Steps:

  • History taking to identify symptoms indicative of urinary tract issues, such as changes in urinary frequency or signs of systemic illness.

  • Physical examination to detect any signs of bladder distension or masses, neurological deficits indicating neurogenic bladder, or enlarged prostate in men which could suggest an obstruction.

  • For suspected bladder outlet obstruction, attempts to relieve it with measures like catheterization are recommended, with considerations for adjustments based on patient response and potential complications.

  • Further Investigations:

  • Additional lab tests including electrolyte panels to check for complications like hyperkalemia or acidosis, and urine analysis for signs of hematuria or renal damage.

  • Imaging studies like KUB (kidney, ureter, and bladder) X-ray or ultrasound to assess for hydronephrosis (swelling of a kidney due to urine build-up) or other obstructions.

  • Management Plan:

  • Notify medical staff for further evaluation and intervention.

  • Consider imaging to identify the cause of obstruction for appropriate treatment, monitoring urine output, and following up on renal function tests to guide management.

This approach emphasizes the importance of a systematic and thorough evaluation to accurately diagnose and manage the cause of anuria or oliguria, ensuring prompt and effective treatment to prevent further renal damage and complications. Discusses the management of Acute Kidney Injury (AKI) with a focus on differentiating pre-renal and renal causes. It emphasizes the importance of identifying the primary cause of AKI and addresses treatment strategies for both pre-renal and renal AKI, including the management of volume status, avoidance of nephrotoxic agents, and specific treatments for conditions like glomerulonephritis and acute tubular necrosis (ATN). The text also covers the use of diuretics, particularly in cases of volume overload, and outlines indications for emergency hemodialysis.

Key Management Strategies for AKI

  • Identification and Management of the Primary Cause: It's crucial to treat the underlying cause of AKI, whether it's volume depletion, sepsis, medication-induced nephrotoxicity, or another factor. For example, inotropic drugs and diuretics may be used for acute decompensated heart failure, while antibiotics are essential for sepsis management.

  • Volume Management: The first step in managing pre-renal AKI is to ensure adequate hydration to prevent the progression to ischemic acute tubular necrosis. However, caution is advised to avoid volume overload, especially in patients with heart failure or those who are susceptible to fluid overload.

  • Renal Cause Management:

  • Glomerulonephritis: Focus on treating the cause, controlling blood pressure, and limiting salt intake to reduce salt and water retention.

  • Acute Tubular Necrosis (ATN): Key strategies include stopping nephrotoxic drugs, maintaining fluid balance (especially during the oliguric phase), and closely monitoring and adjusting treatment during the diuretic phase to ensure adequate fluid replacement.

  • Acute Interstitial Nephritis (AIN): Involves stopping nephrotoxic agents and managing the complications of AKI.

  • Diuretic Therapy: Diuretics, such as Furosemide (Lasix), are used in cases of volume overload. It's important to start with an appropriate dose and adjust based on the patient's response. The maximum recommended dose of Furosemide is 1 g/day.

  • Indications for Emergency Hemodialysis (AEIOU):

  • A: Severe metabolic acidosis not responsive to medical treatment (pH<7.2)

  • E: Electrolyte disturbances not responsive to medical treatment (e.g., hyperkalemia, hypercalcemia)

  • I: Intoxications (e.g., methanol, ethylene glycol, lithium, metformin, valproic acid)

  • O: Volume overload not responsive to high-dose diuretics

  • U: Uremic symptoms (e.g., encephalopathy, nausea/vomiting, pericarditis)

Conclusion

Management of AKI requires a comprehensive approach that includes identifying and treating the primary cause, careful volume management, specific treatment for renal causes, judicious use of diuretics, and consideration of hemodialysis in severe cases. Monitoring and adjusting treatment based on the patient's response and clinical progression are crucial for successful management.

3 views0 comments

Recent Posts

See All

Essential Antibiotic Dosages for Thai Medical Practice

Dose ยา Acetylcysteine (Fluimacil) (200): 1x3 po pc Air-x (80): 1x3 po pc Aldactone (100): 1x1 po pc for cirrhosis Aldosterone (Aldactone) (25): 1x2 1x3 po pc Allopurinol (100) (300): Start 50-100 mg,

Seizures and epilepsy

Seizure Seizure: Sudden behavioral changes resulting from abnormal electrical discharges from brain cells. It is a "symptom" that can be provoked (Provoked Seizure) or occur without a specific trigger

Comments


Post: Blog2_Post
bottom of page